PTIX

Protagenic Therapeutics (PTIX)

Protagenic Therapeutics Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:PTIX

1 2 3 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/02/15	04 : 29	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:PTIX	Protagenic Therapeutics Inc
2023/12/16	05 : 50	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:PTIX	Protagenic Therapeutics Inc
2023/11/30	07 : 18	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:PTIX	Protagenic Therapeutics Inc
2023/11/15	06 : 02	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:PTIX	Protagenic Therapeutics Inc
2023/11/03	05 : 29	Edgar (US Regulatory)	Form DEF 14A - Other definitive proxy statements	NASDAQ:PTIX	Protagenic Therapeutics Inc
2023/10/14	01 : 48	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:PTIX	Protagenic Therapeutics Inc
2023/08/15	04 : 29	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:PTIX	Protagenic Therapeutics Inc
2023/04/18	03 : 44	Edgar (US Regulatory)	Amended Annual Report (10-k/a)	NASDAQ:PTIX	Protagenic Therapeutics Inc
2023/03/23	02 : 29	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:PTIX	Protagenic Therapeutics Inc
2022/11/15	04 : 20	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:PTIX	Protagenic Therapeutics Inc
2022/10/12	19 : 01	Edgar (US Regulatory)	Proxy Statement (definitive) (def 14a)	NASDAQ:PTIX	Protagenic Therapeutics Inc
2022/08/12	05 : 07	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:PTIX	Protagenic Therapeutics Inc
2022/05/13	19 : 36	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:PTIX	Protagenic Therapeutics Inc
2022/03/09	06 : 03	Edgar (US Regulatory)	Securities Registration: Employee Benefit Plan (s-8)	NASDAQ:PTIX	Protagenic Therapeutics Inc
2022/02/15	20 : 17	Edgar (US Regulatory)	Statement of Ownership (sc 13g)	NASDAQ:PTIX	Protagenic Therapeutics Inc
2022/02/05	06 : 33	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:PTIX	Protagenic Therapeutics Inc
2021/11/23	22 : 45	TipRanks	Protagenic Therapeutics (PTIX) Initiated with a Buy at Maxim Group	NASDAQ:PTIX	Protagenic Therapeutics Inc
2021/11/16	23 : 58	GlobeNewswire Inc.	Protagenic Therapeutics Announces Third Quarter 2021 Results and Business Update	NASDAQ:PTIX	Protagenic Therapeutics Inc
2021/11/16	06 : 55	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:PTIX	Protagenic Therapeutics Inc
2021/10/06	06 : 26	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:PTIX	Protagenic Therapeutics Inc
2021/10/02	06 : 20	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:PTIX	Protagenic Therapeutics Inc
2021/09/11	05 : 57	Edgar (US Regulatory)	Securities Registration Statement (simplified Form) (s-3/a)	NASDAQ:PTIX	Protagenic Therapeutics Inc
2021/08/30	22 : 15	GlobeNewswire Inc.	Protagenic Therapeutics to Host Virtual Science Review Wednesday, September 8th at 10 AM ET	NASDAQ:PTIX	Protagenic Therapeutics Inc
2021/08/19	19 : 02	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:PTIX	Protagenic Therapeutics Inc
2021/08/17	20 : 45	GlobeNewswire Inc.	Protagenic Therapeutics Announces Second Quarter 2021 Results and Provides Business Update	NASDAQ:PTIX	Protagenic Therapeutics Inc
2021/08/17	06 : 04	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:PTIX	Protagenic Therapeutics Inc
2021/08/14	06 : 29	Edgar (US Regulatory)	Securities Registration Statement (simplified Form) (s-3)	NASDAQ:PTIX	Protagenic Therapeutics Inc
2021/07/24	05 : 21	GlobeNewswire Inc.	Protagenic Therapeutics Updates Timeline for Commencement of Patient Enrollment for PT00114 Clinical Trial	NASDAQ:PTIX	Protagenic Therapeutics Inc
2021/07/06	19 : 17	GlobeNewswire Inc.	Protagenic Therapeutics to Host Webinar with Dr. Maurizio Fava for its Lead Molecule PT00114 on Tuesday, July 13th at 10:00 A...	NASDAQ:PTIX	Protagenic Therapeutics Inc
2021/07/03	05 : 50	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:PTIX	Protagenic Therapeutics Inc